GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Cyclically Adjusted PS Ratio

Universal Biosensors (ASX:UBI) Cyclically Adjusted PS Ratio : 1.41 (As of May. 05, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Cyclically Adjusted PS Ratio?

As of today (2024-05-05), Universal Biosensors's current share price is A$0.155. Universal Biosensors's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was A$0.11. Universal Biosensors's Cyclically Adjusted PS Ratio for today is 1.41.

The historical rank and industry rank for Universal Biosensors's Cyclically Adjusted PS Ratio or its related term are showing as below:

ASX:UBI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.93   Med: 2.17   Max: 7.62
Current: 1.37

During the past years, Universal Biosensors's highest Cyclically Adjusted PS Ratio was 7.62. The lowest was 0.93. And the median was 2.17.

ASX:UBI's Cyclically Adjusted PS Ratio is ranked better than
66.03% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.125 vs ASX:UBI: 1.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Universal Biosensors's adjusted revenue per share data for the three months ended in Dec. 2023 was A$0.010. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is A$0.11 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Universal Biosensors Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Universal Biosensors's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Cyclically Adjusted PS Ratio Chart

Universal Biosensors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 3.19 7.42 1.89 1.77

Universal Biosensors Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 2.38 2.26 2.37 1.77

Competitive Comparison of Universal Biosensors's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Universal Biosensors's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Biosensors's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Cyclically Adjusted PS Ratio falls into.



Universal Biosensors Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Universal Biosensors's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.155/0.11
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Biosensors's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Universal Biosensors's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.01/125.6559*125.6559
=0.010

Current CPI (Dec. 2023) = 125.6559.

Universal Biosensors Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.008 97.887 0.010
201406 0.009 98.352 0.011
201409 0.011 98.816 0.014
201412 0.026 99.002 0.033
201503 0.022 99.187 0.028
201506 0.035 99.838 0.044
201509 0.034 100.302 0.043
201512 0.019 100.673 0.024
201603 0.031 100.488 0.039
201606 0.030 100.859 0.037
201609 0.019 101.602 0.023
201612 0.028 102.159 0.034
201703 0.045 102.624 0.055
201706 0.036 102.809 0.044
201709 0.036 103.460 0.044
201712 0.026 104.110 0.031
201803 0.043 104.574 0.052
201806 0.033 104.945 0.040
201809 0.266 105.410 0.317
201812 0.049 105.967 0.058
201903 0.011 105.967 0.013
201906 0.012 106.617 0.014
201909 0.008 107.174 0.009
201912 0.008 107.917 0.009
202003 0.003 108.289 0.003
202006 0.003 106.246 0.004
202009 0.002 107.917 0.002
202012 0.010 108.846 0.012
202103 0.009 109.496 0.010
202106 0.010 110.332 0.011
202109 0.007 111.168 0.008
202112 0.007 112.654 0.008
202203 0.010 115.069 0.011
202206 0.007 117.112 0.008
202209 0.003 119.248 0.003
202212 0.004 121.477 0.004
202303 0.006 123.148 0.006
202306 0.006 124.170 0.006
202309 0.009 125.656 0.009
202312 0.010 125.656 0.010

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Universal Biosensors  (ASX:UBI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Universal Biosensors Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Biosensors (ASX:UBI) Business Description

Traded in Other Exchanges
N/A
Address
1 Corporate Avenue, Rowville, VIC, AUS, 3178
Universal Biosensors Inc is a developer of biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in its hand-held portable analysers for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture, enabling high speed, ease of use, reliability, accuracy at low cost.

Universal Biosensors (ASX:UBI) Headlines

No Headlines